Assistant Attending
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Dr. Urvi A. Shah, MD, MS is an Assistant Attending in the Myeloma Service at Memorial Sloan Kettering Cancer Center. She is board certified in Internal Medicine, Hematology, Medical Oncology and Lifestyle Medicine and received a Master of Science degree in Clinical and Translational Cancer Research. Her research interests include modifiable risk factors (diet, metabolism, microbiome) in cancer.
She completed the first pilot nutrition trial in plasma cell disorders to date (NUTRIVENTION) and has 5 other dietary trials enrolling that will collectively enroll 600 participants. Results from the first NUTRIVENTION trial have been published in Cancer Discovery and showed that a high fiber plant-based diet improves key cancer risk markers and may delay progression to the cancer myeloma in patients with precursor plasma cell disorders. Dr. Shah has published first author papers in prominent journals such as Cancer Discovery, Blood, and Clinical Cancer Research amongst others and has been an invited speaker and session chair nationally and internationally.
Dr. Shah has been supported by career development awards (National Cancer Institute [NCI] K12, International Myeloma Society and American Society of Hematology [ASH] Scholar) and research awards (ECOG ACRIN Young Investigator Translational Research, Henry Moses, Celgene Future Leaders in Hematology, NCI Early Investigator Advancement Program, Clinical Cancer Research Early Career, ASH David M. Goldenberg CRTI). Her research has been funded by numerous foundations (Blood Cancer United, Gabrielle’s Angel, Allen, Riney, HealthTree, Society of MSK, Comedy vs Cancer and Willow Foundations).
Disclosure information not submitted.
Sunday, November 8, 2026
1:00 PM - 4:00 PM ET